SRXH Tumbles Post-Earnings: Can It Hold the $0.08 Support?

SRx Health (NYSE: SRXH) stock news SRx Health (NYSE: SRXH) has been one of the more volatile names in the micro-cap space in recent sessions. After closing at $0.1485 in regular trading, the stock plunged 14% post-market, settling at $0.1275. That move put it at the bottom end of its 20-day range and extended a bearish trend that’s now been in place for months. While the broader market was mixed—S&P 500 futures dipped 0.08%, Nasdaq futures edged up 0.02%—SRXH’s move drew immediate attention. The key question is: What’s driving this sharp sell-off, and is it a signal of a deeper trend or just a short-term correction?

Why is SRXH stock dropping today? SRXH’s post-market drop was triggered by its Q1 FY26 earnings report. The company reported net revenue of $2.8 million, with a cash balance of $13.1 million but a net loss of $8.6 million. That combination—revenue growth but deep losses—was enough to spark a sharp reaction from traders. The report also mentioned a pending acquisition of EMJ Crypto Technologies, expected to close in the first half of 2026. That deal hasn’t yet moved the needle for the stock, as it’s still in the early stages.

Crucially, the volume tells a story. Today’s trading volume of 39 million shares was well above the 20-day average of 35.7 million, indicating heightened participation. The relative volume of 1.09x suggests a strong confirmation of the price move. That said, the stock’s 20-day moving average is at $0.15, and the 50-day MA is at $0.24. Both lines remain well above the current price, reinforcing the bearish tilt.

SRXH support and resistance levels From a technical standpoint, SRXH is in a clear downtrend. The 14-day RSI at 48.28 suggests it’s not yet in extreme oversold territory, but the price action shows a strong reversal attempt. The nearest resistance sits at $0.1485—coincidentally the prior close—and the nearest support is at $0.0786. That level is a key watchpoint. A break below it would likely trigger a deeper pullback or even a failure scenario.

Looking ahead, the next few sessions will be critical. If SRXH holds above $0.08 and shows signs of stabilizing, it could find a floor. But if it breaks that level with high volume, the bearish case gains strength. The 1.5x ATR target of $0.17 would be a tall order in the current environment, but a move above $0.15 would signal a retest of the 20-day MA and could bring in some short-covering or speculative buyers.

The bottom line: This is a stock with a clear catalyst—earnings—and a strong technical backdrop. The move is real, but it's not yet clear whether it's a short-term selloff or a deeper correction. Traders are watching the key levels closely, and the next 48 hours could tell the story.